QNTM: Quantum BioPharma Ltd. Operating Sales Margin

Quantum BioPharma Corp - graphic logo of issuer QNTM

Quantum BioPharma Ltd (QNTM) is scaling its research and development in CNS pathologies and inflammation, aiming for expansion through B2B partnerships. The operating margin history provided by GURU.Markets clearly illustrates financial resilience, where the value 0.00 represents the current metric. Simultaneously, the company is implementing ESG standards to reduce its carbon footprint, although speculative capital inflows and stringent regulatory oversight limit the stability of its diversified ecosystem.

QNTM - Quantum BioPharma Operating Margin over the range 08/16/2024 - 11/19/2026

Quantum BioPharma Ltd - analytical breakdowns and key metrics (QNTM)

Summary company analysis:Quantum BioPharma Corp, QNTM
Brand item of Quantum BioPharma Corp

Operating margin measures the share of profit from core operations per dollar of revenue, allowing investors to use operating profitability before interest and taxes to separate actual business process efficiency from market speculation. For Quantum BioPharma Ltd (QNTM), this indicator remains volatile, as the lack of stable sales during the clinical research phase leaves the company dependent on external financing.

Competitor analysis

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.